Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pathology

Diagnosing Porphyria: Crucial Lab Tests and Avoidable Mistakes

At a Glance

To accurately diagnose an acute porphyria attack, you must get a random spot urine test for PBG and ALA while actively experiencing symptoms. Relying only on a 'total porphyrins' test is a common medical mistake that can cause your attack to be missed entirely.

Diagnosing porphyria is often described as finding a needle in a haystack, but the real challenge is usually that the wrong “magnet” was used to look for it. Because symptoms like stomach pain or skin rashes are common, the diagnosis depends entirely on very specific laboratory tests [1][2].

The “Gold Standard” for Acute Attacks

If you are experiencing a suspected acute attack (severe abdominal pain, nausea, or confusion), timing is everything. The most critical test must be done while you are symptomatic [3].

  • The Required Test: A random (spot) urine test for Porphobilinogen (PBG) and Delta-aminolevulinic acid (ALA) [1][4].
  • Why it Matters: PBG is the “smoking gun” of an acute porphyria attack. During an attack, PBG levels will be significantly elevated—often 10 to 100 times the normal limit [1][5].

The Most Common Diagnostic Mistake

A frequent error in emergency rooms or clinics is ordering a test for “Total Porphyrins” instead of PBG [1].

  • The Trap: Total porphyrins can be slightly high in many conditions, such as liver disease or heavy alcohol use, leading to a “false positive” that scares patients but doesn’t mean they have porphyria [2].
  • The Risk: Conversely, some patients in the early stages of an acute attack may have high PBG but normal total porphyrins. If a doctor only checks porphyrins, they might tell you the test is “normal” and miss the attack entirely [1][2].

Patient Protection Tip: Always check your lab order. If it says “Urine Porphyrins” but does not explicitly list PBG or Porphobilinogen, ask your doctor to add it [1].

Diagnosing Cutaneous (Skin) Types

For those with skin fragility, blistering, or burning, the diagnostic path is different. Instead of looking for a single chemical, doctors look for a “profile” of porphyrins in several different samples [6][7].

  • The Samples: You will likely need to provide Urine, Blood (Plasma), and Fecal samples [6][8].
  • Plasma Porphyrin Scan: This is a specialized test where the lab shines a specific light through your blood plasma to see how it glows (fluoresces). Different types of porphyria glow at different wavelengths, helping doctors tell the difference between conditions like Porphyria Cutanea Tarda (PCT) and Variegate Porphyria [6][2].

The Role of Genetic Testing

Genetic testing is a powerful tool, but it is often misunderstood. It is usually the second step, not the first [9].

  1. Biochemical First: Tests like urine PBG or plasma scans prove that you are currently sick and your heme pathway is failing [9][10].
  2. Genetic Second: Once biochemistry confirms porphyria, genetic testing identifies the exact “typo” in your DNA. This is vital for confirming your specific subtype and is the only way to accurately screen your family members [11][12]. Confirming the exact genetic mutation empowers your biological family members to get screened and learn their status before they ever experience their first attack, which is an enormous benefit for family planning and prevention [12].

Completeness Checklist for Your Results

When you receive your lab report, ensure it includes these details to be considered a complete evaluation:

Test Component Purpose Requirement
PBG (Urine) Detects acute attacks Must be a “spot” (random) sample, not a 24-hour collection [1].
ALA (Urine) Supports PBG results Often elevated alongside PBG in acute types [3].
Light Protection Preserves the sample The report or lab notes should ideally confirm the sample was “protected from light” [13].
Porphyrin Profile Identifies skin types Includes plasma, urine, and sometimes fecal measurements [6].
Creatinine (Urine) Accuracy check Used to “normalize” the PBG result to ensure the urine wasn’t too dilute [14].

If any of these are missing, your diagnostic picture may be incomplete [1][15].

Return to Home

Common questions in this guide

What is the best test for a suspected acute porphyria attack?
The most critical test during an active attack is a random spot urine test for Porphobilinogen (PBG) and Delta-aminolevulinic acid (ALA). PBG levels rise significantly during an episode, providing a definitive biochemical sign of an acute attack.
Why shouldn't my doctor just order a 'Total Porphyrins' test?
A total porphyrins test can be slightly high due to unrelated conditions like liver disease, causing false alarms. On the other hand, you could be having a severe attack with high PBG but normal total porphyrins, leading a doctor to completely miss the diagnosis.
How is skin-related (cutaneous) porphyria diagnosed?
Skin-related porphyrias require a profile of porphyrins collected from urine, blood plasma, and sometimes stool samples. A specialized plasma porphyrin scan is often used, which shines light through your blood to see how it fluoresces and identifies the specific type.
Do my samples for porphyria testing need special handling?
Yes, samples must be strictly protected from light. Lab technicians should wrap your urine or blood container in foil or dark plastic to preserve the sample so the test results remain accurate.
Should I get genetic testing for porphyria first?
Biochemical tests like a urine PBG check must come first to prove your body is actively failing to process heme. Once these tests confirm porphyria, genetic testing is used as a second step to find your exact DNA mutation and safely screen your family members.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.I am in pain now; can we please order a 'random spot urine PBG and ALA' test immediately?
  2. 2.I noticed the lab order only says 'urine porphyrins.' Can we add PBG (porphobilinogen) to ensure we aren't missing an acute attack?
  3. 3.How will the lab ensure my urine and blood samples are protected from light so the results are accurate?
  4. 4.Now that my biochemical tests are positive, should we proceed with genetic testing to identify the specific mutation for my family's sake?
  5. 5.If my PBG is normal but I have skin blisters, should we order a plasma porphyrin scan to look for Variegate Porphyria or PCT?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Obstacles to Early Diagnosis of Acute Hepatic Porphyria: Current Perspectives on Improving Early Diagnosis and Clinical Management.

    Thapar M, Singh A, Robinson KM, Bonkovsky HL

    Clinical and experimental gastroenterology 2024; (17()):1-8 doi:10.2147/CEG.S348507.

    PMID: 38205357
  2. 2

    Best practice guidelines on first-line laboratory testing for porphyria.

    Woolf J, Marsden JT, Degg T, et al.

    Annals of clinical biochemistry 2017; (54(2)):188-198 doi:10.1177/0004563216667965.

    PMID: 27555665
  3. 3

    AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.

    Wang B, Bonkovsky HL, Lim JK, Balwani M

    Gastroenterology 2023; (164(3)):484-491 doi:10.1053/j.gastro.2022.11.034.

    PMID: 36642627
  4. 4

    Implanted Progestin Causing Pain and Psychiatric Disturbances in Porphyria Attack: A Case Report.

    Misek RK, Riitano MF

    Clinical practice and cases in emergency medicine 2023; (7(3)):144-147 doi:10.5811/cpcem.1490.

    PMID: 37595297
  5. 5

    Acute Porphyrias.

    Besur S, Schmeltzer P, Bonkovsky HL

    The Journal of emergency medicine 2015; (49(3)):305-12.

    PMID: 26159905
  6. 6

    Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.

    Balogun O, Nejak-Bowen K

    Seminars in liver disease 2024; (44(2)):209-225 doi:10.1055/s-0044-1787076.

    PMID: 38772406
  7. 7

    Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.

    Aguilera P, Badenas C, Whatley SD, To-Figueras J

    The British journal of dermatology 2016; (175(6)):1346-1350 doi:10.1111/bjd.14675.

    PMID: 27086902
  8. 8

    Porphyria: awareness is the key to diagnosis!

    Heymans B, Meersseman W

    Acta clinica Belgica 2022; (77(3)):703-709 doi:10.1080/17843286.2021.1918876.

    PMID: 33938396
  9. 9

    Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility.

    Cheema H, Bertoli-Avella AM, Skrahina V, et al.

    NPJ genomic medicine 2020; (5()):44 doi:10.1038/s41525-020-00150-z.

    PMID: 33083013
  10. 10

    Biochemical testing for congenital disorders of glycosylation: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

    Hall PL, Lam C, Wolfe L, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(4)):101328 doi:10.1016/j.gim.2024.101328.

    PMID: 39945761
  11. 11

    Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.

    Weiss Y, Chen B, Yasuda M, et al.

    Molecular genetics and metabolism 2019; (128(3)):363-366 doi:10.1016/j.ymgme.2018.11.013.

    PMID: 30514647
  12. 12

    New Case Detection by Cascade Testing in Familial Hypercholesterolemia: A Systematic Review of the Literature.

    Lee C, Rivera-Valerio M, Bangash H, et al.

    Circulation. Genomic and precision medicine 2019; (12(11)):e002723 doi:10.1161/CIRCGEN.119.002723.

    PMID: 31638829
  13. 13

    Guide for the classification of porphyrias using state-of-the-art reverse-phase high-performance liquid chromatography.

    Laguna J, Wijngaard R, Marés L, et al.

    Scandinavian journal of clinical and laboratory investigation 2025; (85(5)):327-339 doi:10.1080/00365513.2025.2524714.

    PMID: 40600928
  14. 14

    Effect of Menstrual Cycle on Acute Intermittent Porphyria.

    Júnior VRS, Lemos VMV, Feitosa IML, et al.

    Child neurology open 2017; (4()):2329048X17736170 doi:10.1177/2329048X17736170.

    PMID: 29094055
  15. 15

    Practical recommendations for biochemical and genetic diagnosis of the porphyrias.

    Aarsand AK, To-Figueras J, Whatley S, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2025; (45(3)):e16012 doi:10.1111/liv.16012.

    PMID: 38940544

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or a genetic counselor regarding your specific diagnostic tests and lab results.

Get notified when new evidence is published on Porphyria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.